Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$3.02 - $5.37 $78,520 - $139,620
-26,000 Reduced 3.58%
700,200 $0
Q2 2022

Jul 26, 2022

BUY
$2.67 - $4.77 $1,602 - $2,861
600 Added 0.08%
726,200 $2.77 Million
Q4 2021

Jan 31, 2022

SELL
$4.05 - $5.37 $8,100 - $10,740
-2,000 Reduced 0.27%
725,600 $3.17 Million
Q2 2021

Jul 30, 2021

BUY
$3.61 - $5.45 $5,415 - $8,175
1,500 Added 0.21%
727,600 $3.97 Million
Q1 2021

Apr 29, 2021

BUY
$3.14 - $6.14 $71,906 - $140,606
22,900 Added 3.26%
726,100 $2.85 Million
Q4 2020

Jan 28, 2021

SELL
$1.79 - $4.04 $7,697 - $17,372
-4,300 Reduced 0.61%
703,200 $2.2 Million
Q3 2020

Oct 29, 2020

BUY
$1.56 - $2.08 $74,100 - $98,800
47,500 Added 7.2%
707,500 $1.33 Million
Q2 2020

Jul 24, 2020

BUY
$0.94 - $2.21 $7,144 - $16,796
7,600 Added 1.16%
660,000 $1.16 Million
Q1 2020

Apr 29, 2020

BUY
$0.84 - $1.76 $43,764 - $91,696
52,100 Added 8.68%
652,400 $672,000
Q4 2019

Jan 27, 2020

BUY
$1.14 - $1.49 $106,133 - $138,719
93,100 Added 18.36%
600,300 $774,000
Q3 2019

Oct 28, 2019

BUY
$1.04 - $1.44 $13,520 - $18,720
13,000 Added 2.63%
507,200 $634,000
Q2 2019

Jul 30, 2019

BUY
$1.09 - $1.88 $16,459 - $28,388
15,100 Added 3.15%
494,200 $568,000
Q1 2019

Apr 30, 2019

BUY
$1.14 - $2.25 $159,482 - $314,768
139,897 Added 41.24%
479,100 $944,000
Q4 2018

Feb 01, 2019

BUY
$1.02 - $2.05 $36,927 - $74,216
36,203 Added 11.95%
339,203 $360,000
Q3 2018

Nov 05, 2018

BUY
$1.01 - $2.19 $10,100 - $21,900
10,000 Added 3.41%
303,000 $554,000
Q2 2018

Jul 30, 2018

BUY
$1.59 - $2.38 $44,520 - $66,640
28,000 Added 10.57%
293,000 $557,000
Q1 2018

May 02, 2018

BUY
$2.28 - $3.8 $143,868 - $239,780
63,100 Added 31.25%
265,000 $604,000
Q4 2017

Jan 31, 2018

BUY
$2.28 - $6.71 $230,051 - $677,039
100,900 Added 99.9%
201,900 $468,000
Q3 2017

Oct 31, 2017

BUY
$1.15 - $2.29 $116,149 - $231,290
101,000
101,000 $219,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.34B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.